14158 Results (Page 420 of 567)
All Market Research Reports
Japan Palliative Care Market Analysis
Japan's Palliative care market is projected to grow from $813.03 Mn in 2022 to $1561.52 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. The main factors driving the growth would be the growing homecare industry, technological advancements, the ageing population, and government support. The market is segmented by service type and by the end user. Some of the major players include Aichi International Hospital, Anjo Koesei Hospital, Nikko Memorial Hospital, Fukuyama City Hospital, and Home Instead.
Japan Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Japan dermatology drugs market will reach a value of $2.5 Bn from $1.06 Bn in 2022, growing at a CAGR of 11.3% during 2022-2030. The market is primarily dominated by local players such as Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Shionogi & Co., Ltd. The market is driven by an ageing population, increasing awareness of skin diseases, and the launch of new and innovative drugs. The dermatology drug market in Japan is segmented by drug class, drug type, prescription mode, indication, route of administration, end user and distribution channel.
Ireland Telemedicine Market Analysis
This report presents a strategic analysis of the Ireland Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Ireland Telemedicine Market, offering unmatched value, accuracy and expert insights.
Italy Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Italy Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 4.3 % from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is advancement in technology, aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, and Recordati Rare Diseases, among others.
France Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The France Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 3.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is increase in awareness, aging population. The market is segmented by diagnostic method, by treatment, by type. Some key players in this market Sanofi Genzyme, Ox Thera, Dicerna Pharmaceuticals, AGC Biologics, Sernova among others.
Germany Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Germany Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 3% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is government support, aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market include Sanofi S.A, Allena Pharmaceuticals, Inozyme Pharma, Evotec, Dicerna Pharmaceuticals, and Alnylam Pharmaceuticals, among others.
US Myasthenia Gravis Therapeutics Market Analysis
The US Myasthenia Gravis therapeutics market is projected to grow from $418.4 Mn in 2022 to $724.3 Mn by 2030, registering a CAGR of 7.1% during the forecast period of 2022-30. This market engages in all of these activities, including regulatory approvals, the introduction of new products, the purchase of other companies, and joint ventures with them. These strategies will definitely contribute to the growth of the global industry. Major global players in this market are Alexion Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Avadel, Dr. Reddy's Laboratories, Ltd., Fresenius Kabi, AG, Endo Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., Mylan N.V., Aurobindo Pharma, Pfizer, Inc., and Astellas Pharma, Inc.
US Multiple Sclerosis Therapeutics Market Analysis
The US multiple sclerosis therapeutics market is projected to grow from $18.2 Bn in 2022 to $27.7 Bn by 2030, registering a CAGR of 5.38% during the forecast period of 2022?30. The two reasons propelling market expansion are the prevalence of multiple sclerosis (MS) is rising, and funding for MS research is rising as well. Major global players in this market are Abbott (U.S.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Takeda Pharmaceutical Company Limited (Japan), Jazz Pharmaceuticals, Inc. (U.K.), Novartis AG (Switzerland), Biora Therapeutics, Inc. (U.S.), Bausch Health Companies Inc. (Canada), Pfizer Inc. (U.S.), Novartis AG (Switzerland), and Mylan N.V. (U.S.)
Indonesia Diabetes Therapeutics Market Analysis
Indonesia's diabetes therapeutics market is expected to grow from $863 Mn in 2022 to $1,811 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-2030. The increasing awareness regarding the consequences of diabetes in Indonesia as well as supportive government policies to promote diabetes awareness in Indonesia are the major market drivers. The Indonesia diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tatarasa, Dexa Group, and GlaxoSmithKline are the major players in the Indonesia diabetes therapeutics market.
Indonesia Anti Aging Therapeutics Market Analysis
Indonesia's anti-ageing therapeutics market is projected to grow from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.53% for 2022-2030. The market expansion is attributed to the growing elderly population and supportive government policies in Indonesia. The Indonesia anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and distribution channel. Some of the key players in the market include Asa Rén, PT Mitra Asiatek Biosensor, and Procter & Gamble.
India Neurology Devices Market Analysis
India's neurology device market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.80% from 2022 to 2030 and will reach $521 Mn in 2030. The neurology device market in India is expected to grow in the coming years due to factors such as the increasing prevalence of neurological disorders, the availability of new technologies, and the growing healthcare expenditure in the country. The market is segmented by type of device and end user. The key players in the markets are B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, and Nihon Kohden Corporation.
India HIV Therapeutics Market Analysis
By 2030, it is anticipated that the India HIV therapeutics market will reach a value of $389.90 Mn from $250.23 Mn in 2022, growing at a CAGR of 5.7% during 2022-2030. The market is primarily dominated by local players such as Cipla Limited, Aurobindo Pharma, and Hetero Drugs Limited. The market is driven by innovation in research and development, increasing prevalence, and good governance. The HIV therapeutics market in India is segmented by type, product, geography, end user, and distribution channel.
India Diabetes Therapeutics Market Analysis
India's diabetes therapeutics market is expected to grow from $2.61 Bn in 2022 to $6.81 Bn in 2030 with a CAGR of 12.7% for the forecasted year 2022-2030. The increasing awareness about diabetes and its consequences along with the rise in urbanization and improvement in healthcare infrastructure in India is responsible for the expansion of the market. The Indian diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Torrent Pharmaceuticals, Zydus Lifesciences, and GlaxoSmithKline are the major players in the Indian diabetes therapeutics market.
Germany Lung Cancer Drugs Market Analysis
Germany's Lung Cancer Drug Market is projected to grow from $350 Mn in 2022 to $579 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. In Germany, lung cancer has a substantial impact on morbidity, death, and socioeconomic expenses. Many of the major pharmaceutical companies have a strong presence in the German lung cancer drug market, including AstraZeneca, Roche, Pfizer, Bristol-Myers Squibb, Merck & Co., and GlaxoSmithKline, which are driving the growth of the market.
Germany Home Healthcare Market Analysis
Germany's home healthcare market was valued at $13.27 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.13% from 2022 to 2030 and will reach $21.36 Bn in 2030. One of the main reasons propelling the growth of this market is rapid urbanization, cost-effectiveness, and improved living standards. The market is segmented by product and by services. Some key players in this market are Smith & Nephew plc, Knight Health Holdings, Mölnlycke Health Care AB, and ConvaTec Group.
France Oncology Drugs Market Analysis
By 2030, it is anticipated that the France oncology drugs market will reach a value of $12.1 Bn from $5.4 Bn in 2022, growing at a CAGR of 10.6% during 2022-2030. The oncology drug market in France is dominated by a few large pharmaceutical companies such as Sanofi, Novartis, Roche, and Pfizer. The oncology market in France is segmented into different therapeutic areas, such as breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.
China Digital Health Market Analysis
China's Digital Health market is projected to grow from $16.96 Bn in 2022 to $73.42 Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. Driven by national initiatives, population expansion, and diversified healthcare requirements, China's healthcare industry is experiencing faster innovation and adoption. The market is segmented by solution, by deployment, and by end-use. Some of the major players include Alibaba Group Holding Limited, Ping An Good Doctor & Cerner Corporation.
Canada ENT Devices Market Analysis
Canada's ENT device market is likely to grow at a CAGR of 5.75% from a market size of $1.85 Bn in 2022 to $2.89 Bn in 2030. The use of emerging technologies like AI and ML as well as developments in auditory products are boosting the industry's growth. This report is segmented by product type, diagnostic devices, surgical devices, and the end user. Some key players in this market include Sonova, Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf, Cochlear, Stryker, and others.
Canada Dialysis Market Analysis
Canada's Dialysis Market is projected to grow from $9.297 Bn in 2022 to $15.386 Bn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-2030. Advancements in dialysis technology and an increase in government funding for dialysis services are also expected to drive growth in the market. Fresenius Medical Care is the largest provider of dialysis products and services in the world and has a significant presence in the Canadian market.
Canada Anti Aging Therapeutics Market Analysis
Canada's anti-ageing therapeutics market is likely to grow at a CAGR of 16.53% from a market size of $54 Mn in 2022 to $164 Mn in 2030. The major growth drivers driving the market are the growing ageing population and the trend of the shift toward preventive healthcare. This report is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Some key players in this market include Pfizer, Bristol-Myers Squibb Company, Merck, Calico, and others.
Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
This report presents a strategic analysis of the Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy and expert insights.
Brazil Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil Oncology Therapeutics Market will reach a value of $9.3 Bn from $4.5 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in Brazil is dominated by a few domestic pharmaceutical companies such as Cristalia, Eurofarma, and Ache Laboratorios. The Oncology Therapeutics Market in Brazil is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Brazil Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Brazil Medical Devices Market Analysis
This report presents a strategic analysis of the Brazil Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Medical Devices Market, offering unmatched value, accuracy and expert insights.
Belgium Dental Care Market Analysis
Belgium's dental care market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The world’s most advanced healthcare system encourages innovation in dental care and with high standards of care demanded the market is a flourishing ground for players like Dentale, Dental Avenue, and Dental Health Group. This report is segmented by treatment type, age group, clinical setup, and by demography and provides rich insights.
Australia Dialysis Market Analysis
Australia's Dialysis Market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. The incidence of CKD in Australia is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
